Kwells 300microgram tablets

Țară: Regatul Unit

Limbă: engleză

Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)

Cumpara asta acum

Prospect Prospect (PIL)
07-06-2018

Ingredient activ:

Hyoscine hydrobromide

Disponibil de la:

Dexcel-Pharma Ltd

Codul ATC:

N05CM05

INN (nume internaţional):

Hyoscine hydrobromide

Dozare:

300microgram

Forma farmaceutică:

Oral tablet

Calea de administrare:

Oral

Clasă:

No Controlled Drug Status

Tip de prescriptie medicala:

Valid as a prescribable product

Rezumat produs:

BNF: 04060000; GTIN: 5010605242144

Caracteristicilor produsului

                                OBJECT 1
KWELLS 300 MICROGRAM TABLETS
Summary of Product Characteristics Updated 01-May-2018 | Bayer plc
1. Name of the medicinal product
Kwells 300 microgram tablets
2. Qualitative and quantitative composition
Hyoscine Hydrobromide 300 microgram
For excipients, see section 6.1
3. Pharmaceutical form
Tablet
Small pink circular, flat faced tablets with bevelled edges. One face
is bisected by a score line and the
other is plain.
4. Clinical particulars
4.1 Therapeutic indications
For the prevention of travel sickness.
4.2 Posology and method of administration
Tablets to be sucked, chewed or swallowed.
Adults:
1 tablet every 6 hours if required. Do not take more than 3 tablets in
24 hours.
Elderly:
There is no special dosage regimen for the elderly and as such caution
should be exercised
Children:
Children over 10: ½-1 tablet every 6 hours if required. Do not take
more than 1½-3 tablets in 24 hours.
Tablets to be taken up to 30 minutes before the start of the journey
to prevent travel sickness, or at the
onset of nausea.
4.3 Contraindications
Prostatic enlargement, paralytic ileus, pyloric stenosis, glaucoma and
myasthenia gravis.
In addition, Kwells should not be given to patients with a known
sensitivity to hyoscine hydrobromide or
any other component of the product.
4.4 Special warnings and precautions for use
The elderly and patients under medical care (in particular those at
risk of acute urinary retention, or with
cardiovascular, metabolic, gastrointestinal, liver or renal disease,
or suffering from CNS disorders such as
seizures) should consult a doctor before taking this product.
In patients with ulcerative colitis its use may lead to ileus or
megacolon.
Antimuscarinics should be used with caution in persons with Down's
Syndrome.
Caution is advisable in patients with diarrhoea.
Hyperthermia can occur at high ambient temperatures due to decreased
sweating, therefore, Kwells
should be used with caution in patients with fever.
4.5 Interaction with other medicinal products and other forms of
interaction
The ef
                                
                                Citiți documentul complet
                                
                            

Căutați alerte legate de acest produs

Vizualizați istoricul documentelor